Internal Neuromodulation Devices Global Market 2024 – By Trends, Key Drivers, Top Manufacturers, Opportunities Forecast To 2033 | Medtronic PLC, Boston Scientific Corporation, Cyberonics Inc

Internal Neuromodulation Devices
Spread the love

The Internal Neuromodulation Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Internal Neuromodulation Devices Market:
https://www.thebusinessresearchcompany.com/report/internal-neuromodulation-devices-global-market-report

According to The Business Research Company’s Internal Neuromodulation Devices Global Market Report 2024, The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to chronic pain management, aging population, clinical research and trials, neurological disorders prevalence, patient awareness and acceptance.

The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to personalized medicine trends, rising healthcare expenditure, collaborations and partnerships, patient outcomes and real-world evidence, regulatory landscape changes. Major trends in the forecast period include miniaturization and implantable technology, wireless connectivity and remote monitoring, expanded applications for neuromodulation, closed-loop systems for precise modulation, focus on patient-centric design.

The increasing incidence of neurologic diseases is expected to boost the growth of the internal neuromodulation devices market going forward. Neurologic diseases are a broad category of disorders that affect the nervous system, including the brain, spinal cord, and nerves throughout the body. Internal neuromodulation devices are medical devices used to treat neurological and psychiatric disorders by delivering electrical stimulation to specific areas of the nervous system, which can relieve symptoms such as chronic pain, movement disorders, and mood disorders. They can improve patient quality of life by reducing symptoms and allowing them to perform daily activities more easily. For instance, in 2021, according to the Centers for Disease Control and Prevention, a US-based government agency, Alzheimer’s disease affected an estimated 6.2 million Americans aged 65 and older. This number is expected to nearly triple to 14 million by 2060. Moreover, the number of people living with the disease doubles every five years after the age of 65. Therefore, the increasing incidence of neurologic diseases is driving the growth of the internal neuromodulation devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10222&type=smp

The internal neuromodulation devices market covered in this report is segmented –
1) By Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator
2) By Technology Type: Internal Neuromodulation, External Neuromodulation
3) By Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials
4) By Application: Failed Back Surgery Syndrome, Parkinson’s Disease, Urinary Incontinence, Epilepsy, Gastroparesis
5) By End-User: Hospitals, Clinics, Home Healthcare, Community Healthcare

Product innovations are a key trend gaining popularity in the internal neuromodulation devices market. Major companies operating in the internal neuromodulation devices segment are focused on innovating new technologies to sustain their position in the market. For instance, in March 2023, Neuromod Device Ltd., an Ireland-based medical equipment manufacturer, announced that its Lenire system had been granted De Novo clearance by the US Food and Drug Administration (FDA). The Lenire system uses a combination of sound stimulation and tongue stimulation to treat tinnitus, a neurological disorder characterized by ringing in the ears. The Lenire system uses a dual-pronged approach to neurostimulation. Bluetooth headphones play unique sounds that are intended to stimulate the auditory nerve, while Neuromod’s Tonguetip device is inserted into the mouth and transmits moderate electrical stimulation to the tongue’s surface. Now that the otolaryngologist has access to innovative Lenire technology, he or she can recommend it to patients whose tinnitus is having at least a moderately negative impact on their lives.

The internal neuromodulation devices market report table of contents includes:
1. Executive Summary
2. Internal Neuromodulation Devices Market Characteristics
3. Internal Neuromodulation Devices Market Trends And Strategies
4. Internal Neuromodulation Devices Market – Macro Economic Scenario
5. Global Internal Neuromodulation Devices Market Size and Growth
………………
31. Global Internal Neuromodulation Devices Market Competitive Benchmarking
32. Global Internal Neuromodulation Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Internal Neuromodulation Devices Market
34. Internal Neuromodulation Devices Market Future Outlook and Potential Analysis
35. Appendix

Read Related Topics:

Hemodialysis Global Market 2024 – By Growth, Drivers, Growth Trends, Analysis Forecast To 2033 | Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc

Hemoglobin Testing Global Market 2024 – By Trends, Key Drivers, Top Manufacturers, Opportunities Forecast To 2033 | Abbott Laboratories Inc., Bayer Medical Care Inc., Danaher Corporation

Hepatocellular Carcinoma Drugs Global Market 2024 – By Growth, Drivers, Growth Trends, Analysis Forecast To 2033 | AbbVie Inc., Amgen Inc., Bayer AG

Hemodialysis Global Market 2024 – By Trends, Key Drivers, Top Manufacturers, Opportunities Forecast To 2033 | Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc

Hemoglobin Testing Global Market 2024 – By Growth, Drivers, Growth Trends, Analysis Forecast To 2033 | Abbott Laboratories Inc., Bayer Medical Care Inc., Danaher Corporation

Hepatocellular Carcinoma Drugs Global Market 2024 – By Trends, Key Drivers, Top Manufacturers, Opportunities Forecast To 2033 | AbbVie Inc., Amgen Inc., Bayer AG

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →

Leave a Reply

Your email address will not be published. Required fields are marked *